Filgrastim Recruiting Phase 2 Trials for Acute Lymphoblastic Leukaemias (ALL) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03318419Cladribine in Combination With GAP in Patients With Refractory/Relapsed Acute Lymphoblastic Leukemia